Clinical Trial Update: A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating different weekly doses of NNC0148-0287 C (Insulin 287) for blood sugar control in people with Type 1 diabetes; the trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0148-0287 C (Insulin 287)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED